VYNE Therapeutics (VYNE)
(Real Time Quote from BATS)
$1.69 USD
-0.08 (-4.52%)
Updated Aug 9, 2024 03:54 PM ET
After-Market: $1.63 -0.06 (-3.55%) 4:14 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Earnings News For VYNE
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
-
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
-
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
-
VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q4 Loss, Misses Revenue Estimates